Long-Term Risks of Paroxetine in Adults Aged 40–50 YearsAnticholinergic BurdenSexual DysfunctionDiscontinuation SyndromeDrug‑Interaction PotentialBleeding RiskHyponatremiaCardiovascular ConsiderationsPreferred First‑Line AlternativesAlternative Options When Specific Symptoms PredominateTreatment Duration Recommendations